Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Effects of different concentrations of ropivacaine on ankle blocks for foot surgery

Official title: The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ultrasound-guided Ankle Blocks in Patients Undergoing Hallux Valgus Repair Surgery - a Randomized, Double-blinded, Parallel-group Interventional Study

Run by Ziekenhuis Oost-Limburg · NCT06185608 · Data updated 2026-11-12

This study tests whether using different strengths of ropivacaine for ankle blocks can help people having foot surgery feel less pain and recover faster.

More Hallux Valgus trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment174 (estimated)
SponsorZiekenhuis Oost-Limburg
Academic / other
Locations1 site (Genk, Limburg)
StatusRecruiting
StartedMay 22, 2025
Main results expectedMay 1, 2027
Study endsOctober 1, 2027
Registry record updatedMarch 24, 2026
Trial IDNCT06185608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 75 scheduled for elective forefoot surgery for hallux valgus repair who can provide informed consent and perform sensory assessments.

Probably not a fit

Patients with preexisting lower extremity neuropathy, contraindications to ankle block, or allergies to local anesthetics may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates how varying concentrations of ropivacaine (0.25%, 0.5%, and 1%) affect the onset time and duration of ultrasound-guided ankle blocks in patients undergoing forefoot surgery for hallux valgus repair. The research aims to determine whether higher concentrations lead to faster onset and longer sensory block duration, which could improve postoperative analgesia. Primary outcomes include the duration of sensory blocks, while secondary outcomes assess onset time, motor function, pain scores, opioid consumption, and block failure rates.

Why it matters

Potential benefit: If successful, this study could enhance pain management strategies for patients undergoing forefoot surgery, leading to improved recovery experiences.

How similar studies have gone: While the effects of ropivacaine concentrations have been studied in other contexts, this specific evaluation of ultrasound-guided ankle blocks is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provide signed and dated informed consent
* Age 18 up to and including 75 years, scheduled for elective forefoot surgery for hallux valgus repair, with or without one or more of the following: minor toe procedures, osteotomies, arthrodesis or toe extensor/flexor procedures, under unilateral ankle block at ZOL Genk
* ASA physical I-II-III
* Able to ambulate (ability to walk independently, with or without assistive devices)
* Able to learn and perform study sensory and motor assessment by exhibiting sensitivity to pinprick, cold, and light touch (tested beforehand with pinprick/cold/ light touch sensation test) as the patient will have to perform these sensory and motor assessments by him/herself at home at postoperative day 0 to 2

Exclusion Criteria:

* Language barrier
* Preexisting lower extremity neuropathy
* Contraindications to ankle block (local infection, edema, burn, soft tissue trauma, or distorted anatomy with scarring in the area of block placement)
* Contraindications for use of NSAIDs
* Allergy to local anesthetics
* Uncontrolled anxiety, psychiatric or neurological disorder that might interfere with study assessment
* Weight below 50 kg based on a maximum dose of 3 mg/kg ropivacaine and a maximum dose of 150 mg ropivacaine.
* Preoperative use of opioids or gabapentin less than 3 days before surgery
* Contraindications for use of paracetamol
* Contraindications for use of tramadol

Where it's running

  • Ziekenhuis Oost-Limburg
    Genk, Limburg, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.